AKT1 and androgen insensitivity syndrome: Therefore, drugs that boost AKT activity may symbolize a new class of therapeutics against AIS, which is in agreement with our experimental data demonstrating that VK could dramatically stimulate the PI3K–Akt pathway to exert neuroprotective activity.